187 related articles for article (PubMed ID: 20375816)
21. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.
Oonk MHM; Planchamp F; Baldwin P; Bidzinski M; Brännström M; Landoni F; Mahner S; Mahantshetty U; Mirza M; Petersen C; Querleu D; Regauer S; Rob L; Rouzier R; Ulrikh E; van der Velden J; Vergote I; Woelber L; van der Zee AGJ
Int J Gynecol Cancer; 2017 May; 27(4):832-837. PubMed ID: 28441255
[TBL] [Abstract][Full Text] [Related]
22. Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials?
Mitchell C
Arch Dis Child; 2007 Nov; 92(11):1024-7. PubMed ID: 17954482
[No Abstract] [Full Text] [Related]
23. European move affects academic trials research.
Sinha G
J Natl Cancer Inst; 2006 Aug; 98(16):1100-1. PubMed ID: 16912258
[No Abstract] [Full Text] [Related]
24. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
25. Trial and error.
Printz C
Cancer; 2013 Feb; 119(3):471-2. PubMed ID: 23341304
[No Abstract] [Full Text] [Related]
26. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie-Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Virchows Arch; 2018 Jun; 472(6):919-936. PubMed ID: 29725757
[TBL] [Abstract][Full Text] [Related]
27. Good practice for publishing the results of clinical trials.
Wager E
J Br Menopause Soc; 2005 Sep; 11(3):109-11. PubMed ID: 16157002
[TBL] [Abstract][Full Text] [Related]
28. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
Legler UF
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
[TBL] [Abstract][Full Text] [Related]
29. Clinical investigators and the pharmaceutical industry.
Newman TJ
N Engl J Med; 2000 Aug; 343(7):510-1. PubMed ID: 10950675
[No Abstract] [Full Text] [Related]
30. Good pharma? Bad pharma? Better pharma.
Hardman M
J R Coll Physicians Edinb; 2014; 44(4):269-72. PubMed ID: 25516893
[No Abstract] [Full Text] [Related]
31. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
32. An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials.
DeGeorge J; Robertson S; Butler L; Derzi M; Stoch SA; Diaz D; Hartke J; Guzzie-Peck P; Mortimer-Cassen E; Bogdanffy M; Will Y; Greene N
Clin Pharmacol Ther; 2018 Apr; 103(4):566-569. PubMed ID: 29285748
[TBL] [Abstract][Full Text] [Related]
33. Certification requirements for gynecologic oncology versus pelvic surgery: is gynecologic oncology too narrowing?
Moore JG
Obstet Gynecol; 1982 Dec; 60(6):715-7. PubMed ID: 7145272
[No Abstract] [Full Text] [Related]
34. [Clinical researchers and the pharmaceutical industry. Usefulness and need for an independent steering committee].
Van Gijn J; Algra A
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1477-9. PubMed ID: 10443264
[TBL] [Abstract][Full Text] [Related]
35. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
Felgenhauer J; Hooke MC
Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
[TBL] [Abstract][Full Text] [Related]
36. Conducting clinical studies in Italy.
Donawa M
Med Device Technol; 2005 Oct; 16(8):21-4. PubMed ID: 16355966
[TBL] [Abstract][Full Text] [Related]
37. European researchers up in arms over new clinical trials edict.
Bosch X
Nat Med; 2003 Nov; 9(11):1336. PubMed ID: 14595413
[No Abstract] [Full Text] [Related]
38. Efficacy and quality in clinical trials. Requirements to the investigator site. European Economic Community.
Friederichs E; Spitzer SG; Bach R
Arzneimittelforschung; 1994 Feb; 44(2):182-4. PubMed ID: 8147953
[TBL] [Abstract][Full Text] [Related]
39. Academic versus industry-driven research in upper gastrointestinal cancer: sinners and saints.
Hendlisz A; Charette N; Awada A; Deleporte A
Curr Opin Oncol; 2013 Jul; 25(4):407-8. PubMed ID: 23673411
[No Abstract] [Full Text] [Related]
40. Optimal management of recurrent ovarian cancer.
Markman M
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S40-3. PubMed ID: 19955913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
